Next Article in Journal
Pharmacokinetic Covariates Influencing Mycophenolate Area Under the Curve in a Danish Renal Transplant Population
Previous Article in Journal
Therapeutic Potential of Allomyrinasin in Oral Squamous Cell Carcinoma via Decreased NBC Activity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Li et al. Multifunctional Fe3O4@ZIF-8 Nanoparticles with Antibiosis and Osteogenesis for Treatment of Jaw Osteomyelitis. Pharmaceutics 2026, 18, 359

1
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Oral and Maxillofacial Surgery, School of Stomatology, The Fourth Military Medical University, Xi’an 710032, China
2
Frontier Institute of Science and Technology, Interdisciplinary Research Center of Frontier Science and Technology, Xi’an Key Laboratory of Electronic Devices and Material Chemistry, School of Future Technology, Xi’an Jiaotong University, Xi’an 710054, China
3
School of Stomatology, Jiamusi University, 258 Xuefu Street, Xiangyang District, Jiamusi 154007, China
4
Xi’an Gaoxin No. 1 High School, No. 78 Xifengfu Road, Yanta District, Xi’an 710119, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Pharmaceutics 2026, 18(5), 623; https://doi.org/10.3390/pharmaceutics18050623 (registering DOI)
Submission received: 11 May 2026 / Accepted: 14 May 2026 / Published: 20 May 2026

Error in Figure

In the original publication [1], there was a mistake in Figure 3G,I as published. We wish to correct the error in the y-axis label of the quantitative analysis graphs for RUNX2 protein in Figure 3G,I. The original incorrect label was OCN/GAPDH, and it will be revised to the correct title RUNX2/GAPDH. The corrected Figure 3 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Li, H.; Zhang, Z.; Wang, Y.; Mou, T.; Tian, J.; Huang, C.; Zhao, L.; Ge, Z.; Wang, D.; Li, C.; et al. Multifunctional Fe3O4@ZIF-8 Nanoparticles with Antibiosis and Osteogenesis for Treatment of Jaw Osteomyelitis. Pharmaceutics 2026, 18, 359. [Google Scholar] [CrossRef] [PubMed]
Figure 3. In vitro osteogenic effect of Fe3O4@ZIF-8 NPs. (A,B): ALP staining and quantification of ALP activity after osteogenic induction for 7 and 14 days; (C,D): ARS staining and semi-quantitative analysis after 21 days of osteogenic induction; (E): Relative mRNA expression levels of osteogenesis-related genes (Alp, Ocn, and Runx2) after induction for 7 and 14 days; (FI): Western blot and quantification of osteogenesis-related proteins (ALP, OCN, and RUNX2) after induction for 7 (F,G) and 14 (H,I) days. n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
Figure 3. In vitro osteogenic effect of Fe3O4@ZIF-8 NPs. (A,B): ALP staining and quantification of ALP activity after osteogenic induction for 7 and 14 days; (C,D): ARS staining and semi-quantitative analysis after 21 days of osteogenic induction; (E): Relative mRNA expression levels of osteogenesis-related genes (Alp, Ocn, and Runx2) after induction for 7 and 14 days; (FI): Western blot and quantification of osteogenesis-related proteins (ALP, OCN, and RUNX2) after induction for 7 (F,G) and 14 (H,I) days. n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.
Pharmaceutics 18 00623 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, H.; Zhang, Z.; Wang, Y.; Mou, T.; Tian, J.; Huang, C.; Zhao, L.; Ge, Z.; Wang, D.; Li, C.; et al. Correction: Li et al. Multifunctional Fe3O4@ZIF-8 Nanoparticles with Antibiosis and Osteogenesis for Treatment of Jaw Osteomyelitis. Pharmaceutics 2026, 18, 359. Pharmaceutics 2026, 18, 623. https://doi.org/10.3390/pharmaceutics18050623

AMA Style

Li H, Zhang Z, Wang Y, Mou T, Tian J, Huang C, Zhao L, Ge Z, Wang D, Li C, et al. Correction: Li et al. Multifunctional Fe3O4@ZIF-8 Nanoparticles with Antibiosis and Osteogenesis for Treatment of Jaw Osteomyelitis. Pharmaceutics 2026, 18, 359. Pharmaceutics. 2026; 18(5):623. https://doi.org/10.3390/pharmaceutics18050623

Chicago/Turabian Style

Li, Heng, Zhiyue Zhang, Yu Wang, Ting Mou, Jiaqi Tian, Chong Huang, Lu Zhao, Zeyang Ge, Dandan Wang, Chenlu Li, and et al. 2026. "Correction: Li et al. Multifunctional Fe3O4@ZIF-8 Nanoparticles with Antibiosis and Osteogenesis for Treatment of Jaw Osteomyelitis. Pharmaceutics 2026, 18, 359" Pharmaceutics 18, no. 5: 623. https://doi.org/10.3390/pharmaceutics18050623

APA Style

Li, H., Zhang, Z., Wang, Y., Mou, T., Tian, J., Huang, C., Zhao, L., Ge, Z., Wang, D., Li, C., Wang, J., Zheng, Y., Tian, L., & Zong, C. (2026). Correction: Li et al. Multifunctional Fe3O4@ZIF-8 Nanoparticles with Antibiosis and Osteogenesis for Treatment of Jaw Osteomyelitis. Pharmaceutics 2026, 18, 359. Pharmaceutics, 18(5), 623. https://doi.org/10.3390/pharmaceutics18050623

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop